GM-CSF Enhances macrophage glycolytic activity in vitro and improves detection of inflammation in vivo

Journal of Nuclear Medicine

Volumn 57, Issue 9, 2016, Pages 1428-1435

  Singh, Parmanand ^a   González Ramos, Silvia ^b   Mojena, Marina ^b   Rosales Mendoza, César Eduardo ^b,c   Emami, Hamed ^d   Swanson, Jeffrey ^d   Morss, Alex ^d   Fayad, Zahi A ^e   Rudd, James H F ^f   Gelfand, Jeffrey ^d   Paz García, Marta ^b   Martín Sanz, Paloma ^b,g   Boscá, Lisardo ^b,g   Tawakol, Ahmed ^d  

^a NEW YORK PRESBYTERIAN HOSPITAL   (United States)

^b INSTITUTO DE INVESTIGACIONES BIOMÉDICAS ALBERTO SOLS   (Spain)

^c UNIVERSIDAD AUTÓNOMA DE NUEVO LEÓN   (Mexico)

^d MASSACHUSETTS GENERAL HOSPITAL   (United States)

^e MOUNT SINAI SCHOOL OF MEDICINE   (United States)

^f UNIVERSITY OF CAMBRIDGE   (United Kingdom)

^g INSTITUTO DE SALUD CARLOS III   (Spain)

Author keywords

18 F FDG PET; Glycolysis; GM CSF; Inflammation; Macrophage

Indexed keywords

6 PHOSPHOFRUCTO 2 KINASE; DEOXYGLUCOSE; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; TUMOR NECROSIS FACTOR; FLUORODEOXYGLUCOSE F 18; RADIOPHARMACEUTICAL AGENT;

ANALYSIS OF VARIANCE; ARTICLE; ATHEROGENESIS; CELL DENSITY; CONTROLLED STUDY; DENDRITIC CELL; GLYCOLYSIS; HISTOPATHOLOGY; HUMAN; HUMAN CELL; IMAGE ANALYSIS; IMMUNE RESPONSE; IN VITRO STUDY; IN VIVO STUDY; INFLAMMATION; ISOTOPE LABELING; MACROPHAGE; NEUTROPHIL; NEW ZEALAND WHITE (RABBIT); PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; PROTEIN PHOSPHORYLATION; UBIQUITINATION; ANIMAL; ARTERITIS; CELL CULTURE; DIAGNOSTIC IMAGING; DRUG EFFECTS; IMAGE ENHANCEMENT; MALE; METABOLISM; MOUSE; POSITRON EMISSION TOMOGRAPHY; PROCEDURES; RABBIT; REPRODUCIBILITY; SENSITIVITY AND SPECIFICITY;

ANIMALS; ARTERITIS; CELLS, CULTURED; FLUORODEOXYGLUCOSE F18; GLYCOLYSIS; GRANULOCYTE-MACROPHAGE COLONY-STIMULATING FACTOR; HUMANS; IMAGE ENHANCEMENT; MACROPHAGES; MALE; MICE; POSITRON-EMISSION TOMOGRAPHY; RABBITS; RADIOPHARMACEUTICALS; REPRODUCIBILITY OF RESULTS; SENSITIVITY AND SPECIFICITY;

EID: 84989345385     PISSN: 01615505     EISSN: 2159662X     Source Type: Journal    
DOI: 10.2967/jnumed.115.167387     Document Type: Article

References (39)

1. Blankstein R, Osborne M, Naya M, et al. Cardiac positron emission tomography enhances prognostic assessments of patients with suspected cardiac sarcoidosis. J Am Coll Cardiol. 2014;63:329-336.
2. Osborne MT, Hulten EA, Singh A, et al. Reduction in 18F-fluorodeoxyglucose uptake on serial cardiac positron emission tomography is associated with improved left ventricular ejection fraction in patients with cardiac sarcoidosis. J Nucl Cardiol. 2014;21:166-174.
3. Ricciardi A, Sordillo P, Ceccarelli L, et al. 18-fluoro-2-deoxyglucose positron emission tomography-computed tomography: An additional tool in the diagnosis of prosthetic valve endocarditis. Int J Infect Dis. 2014;28:219-224.
4. Sarrazin JF, Philippon F, Tessier M, et al. Usefulness of fluorine-18 positron emission tomography/computed tomography for identification of cardiovascular implantable electronic device infections. J Am Coll Cardiol. 2012;59:1616- 1625.
5. Tahara N, Mukherjee J, de Haas HJ, et al. 2-deoxy-2-[18F]fluoro-D-mannose positron emission tomography imaging in atherosclerosis. Nat Med. 2014;20:215- 219.
6. Go AS, Mozaffarian D, Roger VL, et al. Heart disease and stroke statistics: 2014 update-A report from the American Heart Association. Circulation. 2014;129: E28-e292.
7. Libby P, Ridker PM, Maseri A. Inflammation and atherosclerosis. Circulation. 2002;105:1135-1143.
8. Libby P. Inflammation in atherosclerosis. Nature. 2002;420:868-874.
9. Tawakol A, Singh P, Mojena M, et al. HIF-1alpha and PFKFB3 mediate a tight relationship between proinflammatory activation and anaerobic metabolism in atherosclerotic macrophages. Arterioscler Thromb Vasc Biol. 2015;35:1463- 1471.
10. Tawakol A, Migrino RQ, Hoffmann U, et al. Noninvasive in vivo measurement of vascular inflammation with F-18 fluorodeoxyglucose positron emission tomography. J Nucl Cardiol. 2005;12:294-301.
11. Rudd JH, Myers KS, Bansilal S, et al. Relationships among regional arterial inflammation, calcification, risk factors, and biomarkers: A prospective fluorodeoxyglucose positron-emission tomography/computed tomography imaging study. Circ Cardiovasc Imaging. 2009;2:107-115.
12. Pedersen SF, Graebe M, Fisker Hag AM, Hojgaard L, Sillesen H, Kjaer A. Gene expression and 18FDG uptake in atherosclerotic carotid plaques. Nucl Med Commun. 2010;31:423-429.
13. Figueroa AL, Abdelbaky A, Truong QA, et al. Measurement of arterial activity on routine FDG PET/CT images improves prediction of risk of future CVevents. JACC Cardiovasc Imaging. 2013;6:1250-1259.
14. Rominger A, Saam T, Wolpers S, et al. 18F-FDG PET/CT identifies patients at risk for future vascular events in an otherwise asymptomatic cohort with neoplastic disease. J Nucl Med. 2009;50:1611-1620.
15. Fejer G, Wegner MD, Gyory I, et al. Nontransformed, GM-CSF-dependent macrophage lines are a unique model to study tissue macrophage functions. Proc Natl Acad Sci USA. 2013;110:E2191-E2198.s
16. Fleetwood AJ, Lawrence T, Hamilton JA, Cook AD. Granulocyte-macrophage colony-stimulating factor (CSF) and macrophage CSF-dependent macrophage phenotypes display differences in cytokine profiles and transcription factor activities: implications for CSF blockade in inflammation. J Immunol. 2007;178:5245- 5252.
17. Lacey DC, Achuthan A, Fleetwood AJ, et al. Defining GM-CSF-And macrophage- CSF-dependent macrophage responses by in vitro models. J Immunol. 2012;188:5752-5765.
18. Sugawara Y, Fisher SJ, Zasadny KR, Kison PV, Baker LH, Wahl RL. Preclinical and clinical studies of bone marrow uptake of fluorine-1-fluorodeoxyglucose with or without granulocyte colony-stimulating factor during chemotherapy. J Clin Oncol. 1998;16:173-180.
19. Miki T, Miura T, Nishino Y, et al. Granulocyte colony stimulating factor/macrophage colony stimulating factor improves postinfarct ventricular function by suppression of border zone remodelling in rats. Clin Exp Pharmacol Physiol. 2004;31:873-882.
20. Yano T, Miura T, Whittaker P, et al. Macrophage colony-stimulating factor treatment after myocardial infarction attenuates left ventricular dysfunction by accelerating infarct repair. J Am Coll Cardiol. 2006;47:626-634.
21. Bosca L, Rousseau GG, Hue L. Phorbol 12-myristate 13-Acetate and insulin increase the concentration of fructose 2, 6-bisphosphate and stimulate glycolysis in chicken embryo fibroblasts. Proc Natl Acad Sci USA. 1985;82:6440-6444.
22. Rodríguez-Prados JC, Traves PG, Cuenca J, et al. Substrate fate in activated macrophages: A comparison between innate, classic, and alternative activation. J Immunol. 2010;185:605-614.
23. Baumgartner HR. A new method for the induction of thrombi by controlled overdilatation of the vascular wall [in German]. Z Gesamte Exp Med. 1963;137:227- 247.
24. Tawakol A, Migrino RQ, Bashian GG, et al. In vivo 18F-fluorodeoxyglucose positron emission tomography imaging provides a noninvasive measure of carotid plaque inflammation in patients. J Am Coll Cardiol. 2006;48:1818- 1824.
25. Arnberg H, Letocha H, Nou F, Westlin JF, Nilsson S. GM-CSF in chemotherapyinduced febrile neutropenia: A double-blind randomized study. Anticancer Res. 1998;18:1255-1260.
26. Campbell IK, van Nieuwenhuijze A, Segura E, et al. Differentiation of inflammatory dendritic cells is mediated by NF-kappaB1-dependent GM-CSF production in CD4 T cells. J Immunol. 2011;186:5468-5477.
27. Dhar-Mascareno M, Chen J, Zhang RH, Carcamo JM, Golde DW. Granulocytemacrophage colony-stimulating factor signals for increased glucose transport via phosphatidylinositol 3-kinase-And hydrogen peroxide-dependent mechanisms. J Biol Chem. 2003;278:11107-11114.
28. Khameneh HJ, Isa SA, Min L, Nih FW, Ruedl C. GM-CSF signalling boosts dramatically IL-1 production. PLoS One. 2011;6:e23025.
29. Kim HJ, Oh JS, An SS, et al. Hypoxia-specific GM-CSF-overexpressing neural stem cells improve graft survival and functional recovery in spinal cord injury. Gene Ther. 2012;19:513-521.
30. Schneider UC, Schilling L, Schroeck H, Nebe CT, Vajkoczy P, Woitzik J. Granulocytemacrophage colony-stimulating factor-induced vessel growth restores cerebral blood supply after bilateral carotid artery occlusion. Stroke. 2007;38:1320-1328.
31. Spielholz C, Heaney ML, Morrison ME, Houghton AN, Vera JC, Golde DW. Granulocyte-macrophage colony-stimulating factor signals for increased glucose uptake in human melanoma cells. Blood. 1995;85:973-980.
32. Kleemann R, Zadelaar S, Kooistra T. Cytokines and atherosclerosis: A comprehensive review of studies in mice. Cardiovasc Res. 2008;79:360-376.
33. Abdel-Latif A, Bolli R, Zuba-Surma EK, Tleyjeh IM, Hornung CA, Dawn B. Granulocyte colony-stimulating factor therapy for cardiac repair after acute myocardial infarction: A systematic review and meta-Analysis of randomized controlled trials. Am Heart J. 2008;156:216-226 e219.
34. Domanchuk K, Ferrucci L, Guralnik JM, et al. Progenitor cell release plus exercise to improve functional performance in peripheral artery disease: The PROPEL Study. Contemp Clin Trials. 2013;36:502-509.
35. Subramaniyam V, Waller EK, Murrow JR, et al. Bone marrow mobilization with granulocyte macrophage colony-stimulating factor improves endothelial dysfunction and exercise capacity in patients with peripheral arterial disease. Am Heart J. 2009;158:53-60.e1.
36. Blockmans D, Knockaert D, Maes A, et al. Clinical value of [18F]fluoro-deoxyglucose positron emission tomography for patients with fever of unknown origin. Clin Infect Dis. 2001;32:191-196.
37. Bleeker-Rovers CP, de Kleijn EM, Corstens FH, van der Meer JW, Oyen WJ. Clinical value of FDG PET in patients with fever of unknown origin and patients suspected of focal infection or inflammation. Eur J Nucl Med Mol Imaging. 2004;31:29-37.
38. Lardinois D, Weder W, Hany TF, et al. Staging of non-small-cell lung cancer with integrated positron-emission tomography and computed tomography. N Engl J Med. 2003;348:2500-2507.
39. Satomi T, Ogawa M, Mori I, et al. Comparison of contrast agents for atherosclerosis imaging using cultured macrophages: FDG versus ultrasmall superparamagnetic iron oxide. J Nucl Med. 2013;54:999-1004.